Legal & General Group Plc Makes New $491.92 Million Investment in Synopsys, Inc. $SNPS

Legal & General Group Plc purchased a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,102,793 shares of the semiconductor company’s stock, valued at approximately $491,923,000. Legal & General Group Plc owned approximately 0.58% of Synopsys as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of SNPS. Sankala Group LLC acquired a new stake in shares of Synopsys during the 4th quarter worth approximately $25,000. Elevation Wealth Partners LLC raised its position in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 27 shares in the last quarter. Osbon Capital Management LLC bought a new stake in Synopsys during the second quarter worth $25,000. IMG Wealth Management Inc. bought a new stake in Synopsys during the second quarter worth $28,000. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys in the 4th quarter valued at $28,000. Institutional investors own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by company insiders.

Synopsys Stock Up 3.6%

Shares of NASDAQ:SNPS opened at $408.79 on Wednesday. The firm has a market cap of $78.28 billion, a P/E ratio of 94.63, a P/E/G ratio of 2.32 and a beta of 1.23. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $615.79. The business has a fifty day simple moving average of $417.74 and a 200 day simple moving average of $439.85. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s revenue was up 41.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.67 EPS. Analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently weighed in on SNPS shares. Wells Fargo & Company reduced their price objective on Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. Citigroup increased their target price on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. BNP Paribas Exane raised their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. Zacks Research lowered shares of Synopsys from a “strong-buy” rating to a “hold” rating in a report on Friday, August 21st. Finally, Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Eleven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $563.59.

Get Our Latest Analysis on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.